These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10852114)

  • 1. Participation of innate and acquired immunity in atherosclerosis.
    Curtiss LK; Kubo N; Schiller NK; Boisvert WA
    Immunol Res; 2000; 21(2-3):167-76. PubMed ID: 10852114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies.
    Whitman SC; Ramsamy TA
    Can J Physiol Pharmacol; 2006 Jan; 84(1):67-75. PubMed ID: 16845892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate and adaptive immunity in the pathogenesis of atherosclerosis.
    Hansson GK; Libby P; Schönbeck U; Yan ZQ
    Circ Res; 2002 Aug; 91(4):281-91. PubMed ID: 12193460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells in the innate immunity network of atherosclerosis.
    Bonaccorsi I; De Pasquale C; Campana S; Barberi C; Cavaliere R; Benedetto F; Ferlazzo G
    Immunol Lett; 2015 Nov; 168(1):51-7. PubMed ID: 26384623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subpopulations of lymphocytes and monocytes/macrophages at the early stages of human aorta atherosclerosis].
    Zhdanov VS; Chumachenko PV; Cherpachenko NM; Beskrovnova NN; Lavrova NF
    Arkh Patol; 1995; 57(4):67-71. PubMed ID: 8526761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cells in atherosclerosis.
    Zhou X
    Biomed Pharmacother; 2003 Sep; 57(7):287-91. PubMed ID: 14499175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice.
    Tang J; Kozaki K; Farr AG; Martin PJ; Lindahl P; Betsholtz C; Raines EW
    Am J Pathol; 2005 Sep; 167(3):901-12. PubMed ID: 16127167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proatherogenic role for NK cells revealed.
    Linton MF; Major AS; Fazio S
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):992-4. PubMed ID: 15178571
    [No Abstract]   [Full Text] [Related]  

  • 9. Hallmarks of atherosclerotic lesion development with special reference to immune inflammatory mechanisms.
    Lord RS; Bobryshev YV
    Cardiovasc Surg; 2002 Aug; 10(4):405-14. PubMed ID: 12359417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages and immune cells in atherosclerosis: recent advances and novel concepts.
    Cochain C; Zernecke A
    Basic Res Cardiol; 2015; 110(4):34. PubMed ID: 25947006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice.
    Major AS; Wilson MT; McCaleb JL; Ru Su Y; Stanic AK; Joyce S; Van Kaer L; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2351-7. PubMed ID: 15472130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice.
    Whitman SC; Rateri DL; Szilvassy SJ; Yokoyama W; Daugherty A
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1049-54. PubMed ID: 14988092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.
    Roselaar SE; Schonfeld G; Daugherty A
    J Clin Invest; 1995 Sep; 96(3):1389-94. PubMed ID: 7657813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study.
    Millonig G; Malcom GT; Wick G
    Atherosclerosis; 2002 Feb; 160(2):441-8. PubMed ID: 11849669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
    Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
    J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis and the immune system.
    Hansson GK; Berne GP
    Acta Paediatr Suppl; 2004 Dec; 93(446):63-9. PubMed ID: 15702672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis: immunopathogenesis and immunotherapy.
    Ohashi R; Mu H; Yao Q; Chen C
    Med Sci Monit; 2004 Nov; 10(11):RA255-60. PubMed ID: 15507866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis.
    Vanderlaan PA; Reardon CA
    J Lipid Res; 2005 May; 46(5):829-38. PubMed ID: 15772419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Differentiation of Naïve CD4⁺ T Cells: A Tool for Understanding the Development of Atherosclerosis.
    Iborra S; González-Granado JM
    Methods Mol Biol; 2015; 1339():177-89. PubMed ID: 26445789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of innate and acquired antitumor immunity by bystander gammadelta and alphabeta T lymphocytes with Th2 or Tr1 cytokine profiles.
    Seo N; Tokura Y
    J Interferon Cytokine Res; 1999 Jun; 19(6):555-61. PubMed ID: 10433355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.